Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA sequencing of siPI4KIIIβ-transfected lung cancer cells

ABSTRACT: RNA sequencing of siPI4KIIIβ-transfected lung cancer cells

PROVIDER: PRJNA493785 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7939660_1.fastq.gz	Fastqsanger.gz
	SRR7939660_2.fastq.gz	Fastqsanger.gz
	SRR7939670_1.fastq.gz	Fastqsanger.gz
	SRR7939670_2.fastq.gz	Fastqsanger.gz
	SRR7939680_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

RNA sequencing of siPI4KIIIβ-transfected lung cancer cells

Project description:We speculated that Golgi fragmentation in PI4KIIIβ-deficient cells resulted from apoptosis, which initiates caspase-mediated cleavage of the Golgi ribbon at an early stage of the execution phase. Indeed, siPI4KIIIβ-transfected H23 and H2122 lung cancer cell lines demonstrated evidence of apoptosis on the basis of western blotting, flow cytometry, and RNA sequencing, which identified 717 genes up-regulated in shPI4KIIIβ-transfected H23 cells (fold-change > 1.4, P-value < 0.01 by t-test, false discovery rate<10%) that were enriched in, among other Gene Ontology terms, “positive regulation of apoptotic process” (20 genes, P=0.005), “extracellular matrix” (18 genes, P=1.3E-05), and “extracellular matrix organization” (29 genes, P=1.8E-06) (one-sided Fisher’s exact test using Gene Ontology terms). To determine whether apoptosis resulted from impairment of PI4KIIIβ-dependent secretion, we performed conditioned media transfer experiments and found that the proliferative activity of shPI4KIIIβ-transfected cells was rescued by conditioned media from PI4KIIIβ-replete, but not -deficient, cells.

2021-09-01 | GSE120619 | GEO

Gene expression profiling of lung cancer cells transfected with scrambled siRNA and siRNA targeting the ETS2 gene

Project description:ETS2 is a canonical transcriptional factor and member of the ETS family of genes. ETS2 binds to consensus ERE binding sites in a broad spectrum of genes thus affecting many intracellular molecular functions. However, the role of ETS2 in the biology and pathogenesis of lung cancers is still not known. We have found that ETS2 is down-regulated in lung tumors compared to normal lung tissue and the expression of the coding protein of the gene was a significant independent predictor of favorable outcome in NSCLC patients pinpointing to a potential tumor suppressor role for this gene. To better understand its molecular function in NSCLC, we compared and contrasted the transcriptome of lung cancer cells transfected with control siRNA and siRNA targeting ETS2. H441 lung cancer cells were transfected with SMARTpool (Dharmacon)control/scrambled siRNA or siRNA targeting ETS2. Three independent transfections were performed cells with control siRNA and for cells with siRNA specific to ETS2 where each transfection consittutes a biological replicate. Knock-down of ETS2 in all samples was confirmed by quantitative real-time PCR. Total RNA was then profiled using the Human Gene

2013-11-01 | E-GEOD-43459 | biostudies-arrayexpress

RNA sequencing of cells transfected with SSE mimetics

Project description:RNA sequencing of cells transfected with SSE mimetics

| PRJNA674899 | ENA

RNA-Seq Lung Cancer Samples

Project description:RNA-Seq Lung Cancer Samples Metagenome

| PRJNA592132 | ENA

RNA sequencing on A549 lung cancer cell line

Project description:RNA sequencing on A549 lung cancer cell line

| PRJNA527653 | ENA

NCI-H1299 lung cancer cell line transfected with miR-34a and ghR-34a

Project description:Analysis NCI-H1299 lung cancer cells transfected with synthetic oligo mimics for microRNAs (miRNAs) miR-34a and ghR-34a. We developed a 30-nucleotide single-strand RNA (ssRNA), termed “guide hairpin RNA (ghR),” that has a physiological function similar to that of miRNA and siRNA. The ghR caused no innate cytokine response either in vitro or in vivo. In addition, its structure does not contain a passenger strand seed sequence, reducing the potential for off-target effects relative to existing short RNA reagents. Systemic injection of ghR-form miR-34a (ghR-34a) suppressed tumor growth in a mouse model of RAS-induced lung cancer. Furthermore, ghR-34a functioned in a Dicer- and Ago2-independent manner. This novel RNAi technology may provide a novel, safe, and effective nucleic acid drug platform that will increase the clinical usefulness of nucleic acid therapy.

2015-07-29 | GSE71423 | GEO

Human lung cancer Cells: Control vs. FENDRR stably over-expressed lung cancer cells

Project description:Transcriptional profiling of human lung cancer cell lines A549 comparing control cells transfected with an empty lentiviral expression vector pEZ-Lv201 and A549 cells transfected with a pEZ-Lv201-FENDRR. The latter forms a FENDRR stably over-expressed cell lines. Goal was to to assess the alteration of gene expression profiles caused by FENDRR upregulation.

2016-11-15 | GSE89828 | GEO

Gene expression profiling of Calu-6 lung cancer cells transfected with scrambled siRNA and LAPTM4B-specific siRNA

Project description:We recently characterized the adjacent airway field of cancerization in NSCLC by whole transcriptome expression analysis and demonstrated that lysosomal protein transmembrane 4 beta (LAPTM4B) was an elevated field cancerization marker in NSCLCs and in adjacent but not in distant normal-appearing airways. We also found that LAPTM4B was up-regulated in NSCLCs compared to normal lung and promoted anchorage-dependent growth of lung cancer cells. Previous reports suggested that LAPTM4B is activated following metabolic and genotixc stress. The precise role of LAPTM4B in lung cancer cell survival and NSCLC pathogenesis is still elusive. In the present study we sought to examine how LAPTM4B expression levels impact downstream expression profiles and cell signaling in order to gain better insights into the function of this putative oncogene in lung cancer. Calu-6 lung cancer cells were transfected with SMARTpool (Dharmacon)control/scrambled siRNA or siRNA targeting LAPTM4B. Following transfection, cells were cultured in the presence or absence of 10% fetal bovine serum (FBS). Three independent transfections for each condition were performed representing three biological replicates per condition (total number of samples = 12). RNA interference-mediated knock-down of LAPTM4B in samples was confirmed by quantitative real-time PCR. Total RNA was profiled using the Human Gene 1.0 ST platform.

2016-08-01 | E-GEOD-66606 | biostudies-arrayexpress

Proteomic Analysis of LncPTEN1 RNA Pulldown in Lung Cancer Cells Using LC-MS/MS

Project description:This study aims to identify the molecular function of LncPTEN1 in lung cancer and explore its associated proteins and pathways. Using RNA pulldown coupled with mass spectrometry, we investigated the protein interactions of LncPTEN1 in A549 lung cancer cells. The experiment included three biological replicates with samples 1, 2, 3 as control group and samples 4, 5, 6 as LncPTEN1 overexpression group. The study revealed potential binding partners including Vimentin and Trim16, providing insights into the regulatory mechanisms of LncPTEN1 in lung cancer metastasis.

2025-06-23 | PXD057469 | Pride

High-throughput RNA sequencing analysis of human colon cancer cell line HCT116 transfected with LINC00152 siRNA.

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are using RNA sequencing analysis to evaluate the effects of si-LINC00152 on the mRNA of human colon cancer cell line HCT116. Methods: Human colon cancer cell line HCT116 was transfected with a control non-targeting siRNA to cells or transfected with siRNA targeting LINC00152 for 36 hours in DMEM medium (with 10% serum). Total RNA were extracted and detected by Illumina high-throughput RNA sequencing data analysis. 2 independent biological replicates were plated, transfected in parallel for each control and siRNA. Results: Log-fold changes of up- or down-regulated mRNAs between the control and experiment group were selected with a significance threshold of p<0.05. There are 90 mRNAs were up-regulated and 159 were down-regulated in “si-LINC00152” group comparing to “control” group. Conclusions: Our study describes the mRNA changes of human colon cancer cell line HCT116 transfected with LINC00152 siRNA.

2020-02-18 | GSE132519 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data